Breaking Finance News

Ingredion Inc (NYSE:INGR) stock price target raised to $146.00, issued a report today by Zacks Investment Research

Ingredion Inc (NYSE:INGR) had its target price raised to $146.00 by Zacks Investment Research in a report released 9/22/2016. The new target price indicates a possible upside of 0.12% based on the company's last closing price.

Yesterday Ingredion Inc (NYSE:INGR) traded 0.98% higher at $130.09. The company’s 50-day moving average is $135.02 and its 200-day moving average is $122.31. The last closing price is up 7.40% from the 200-day moving average, compared to the S&P 500 which has decreased -0.01% over the same time. 578,868 shares of the stock were exchanged, up from an avg. volume of 547,778

Recent Performance Chart

Ingredion Inc (NYSE:INGR)

Ingredion Inc has PE ratio of 21.01 with a one year low of $84.57 and a one year high of $140.00 and has a market capitalization of $0.

Brief Synopsis About Ingredion Inc (NYSE:INGR)

Ingredion Incorporated (Ingredion) is a global ingredients solutions provider. The Company is engaged in the production and sale of starches and sweeteners for a range of industries. Its operations are classified into four segments: North America, South America, Asia Pacific, and Europe, Middle East and Africa (EMEA). The Company's North America segment includes businesses in the United States, Canada and Mexico. The South America segment includes businesses in Brazil, Colombia, Ecuador and the Southern Cone of South America, which includes Argentina, Chile, Peru and Uruguay. Ingredion's Asia Pacific segment includes businesses in South Korea, Thailand, Malaysia, China, Japan, Indonesia, the Philippines, Singapore, India, Australia and New Zealand. Its EMEA segment includes businesses in the United Kingdom, Germany, South Africa, Pakistan and Kenya. The Company's product line includes starches and sweeteners, animal feed products and edible corn oil.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.

Leave a Reply

Your email address will not be published. Required fields are marked *